ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy.

Xiaomin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.